Microba Life Sciences (ASX:MAP) Retained Earnings: A$-89.32 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Microba Life Sciences Retained Earnings?

Microba Life Sciences ASX:MAP +2.44% Retained Earnings is A$-89.32 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Microba Life Sciences's retained earnings for the quarter that ended in Dec. 2025 was A$-89.32 Mil.

Microba Life Sciences's quarterly retained earnings declined from Dec. 2024 (A$-69.56 Mil) to Jun. 2025 (A$-78.76 Mil) and declined from Jun. 2025 (A$-78.76 Mil) to Dec. 2025 (A$-89.32 Mil).

Microba Life Sciences's annual retained earnings declined from Jun. 2023 (A$-43.88 Mil) to Jun. 2024 (A$-63.82 Mil) and declined from Jun. 2024 (A$-63.82 Mil) to Jun. 2025 (A$-78.76 Mil).

Microba Life Sciences  (ASX:MAP) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Microba Life Sciences Retained Earnings Historical Data

* Premium members only.

The historical data trend for Microba Life Sciences's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microba Life Sciences Retained Earnings Chart

Microba Life Sciences Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Retained Earnings
-31.20 -43.88 -63.82 -78.76

Microba Life Sciences Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only -55.37 -63.82 -69.56 -78.76 -89.32

Microba Life Sciences Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of A$-89.32 Mil mean?
Microba Life Sciences (ASX:MAP) has a Retained Earnings of A$-89.32 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Microba Life Sciences and its competitors.
Is Microba Life Sciences' Retained Earnings too high?
Microba Life Sciences' current Retained Earnings is A$-89.32 Mil.
How does Microba Life Sciences' Retained Earnings compare to TMO and DHR?
Microba Life Sciences' Retained Earnings of A$-89.32 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Diagnostics & Research company?
A good Retained Earnings depends on the Medical Diagnostics & Research industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Microba Life Sciences and its competitors. Microba Life Sciences's current Retained Earnings is A$-89.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microba Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Microba Life Sciences (ASX:MAP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.26, compared to a current price of A$0.04 — trading 83.8% below its estimated fair value. The current Retained Earnings is A$-89.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Microba Life Sciences (ASX:MAP), the current Retained Earnings is A$-89.32 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microba Life Sciences Business Description

Address 324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.